Lazar Andrew, Morrissey Nicholas
Division of Vascular Surgery, Columbia University Irving Medical Center, New York, NY, 10032, USA.
F1000Res. 2020 Feb 18;9. doi: 10.12688/f1000research.20398.1. eCollection 2020.
As associated co-morbidities have transformed over time, the evaluation and management of peripheral arterial disease have evolved as well. New classification systems have been created to better understand the severity of a patient's condition and the risk of amputation. These classifications include the Wound, Ischemia, and Foot Infection (WIfI) and Global Anatomic Staging System (GLASS) classification systems. Through the utility of these systems, a patient's disease can be appropriately staged and managed with medical, endovascular, or surgical therapies or a combination of these. Endovascular therapies specifically have grown with the explosion of new technologies. There are numerous options for patients with disease amenable to endovascular therapy. In this review article, we discuss a number of these different endovascular therapies as well as the new classification systems.
随着相关合并症随时间推移而发生变化，外周动脉疾病的评估和管理也在不断发展。新的分类系统已被创建，以更好地了解患者病情的严重程度和截肢风险。这些分类包括伤口、缺血和足部感染（WIfI）以及全球解剖分期系统（GLASS）分类系统。通过这些系统的应用，可以对患者的疾病进行适当分期，并采用药物、血管内或手术治疗或这些治疗方法的组合进行管理。特别是随着新技术的激增，血管内治疗得到了发展。对于适合血管内治疗的疾病患者有多种选择。在这篇综述文章中，我们讨论了一些不同的血管内治疗方法以及新的分类系统。
